4//SEC Filing
Boyd Thomas A 4
Accession 0001441844-10-000022
CIK 0000835887other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:32 PM ET
Size
12.1 KB
Accession
0001441844-10-000022
Insider Transaction Report
Form 4
Boyd Thomas A
Sr. VP, Product Dev.
Transactions
- Tax Payment
Common Stock
2010-04-01$5.36/sh−2,385$12,784→ 39,034 total - Exercise/Conversion
ESPP (right to buy)
2010-04-01−2,621→ 0 totalExercise: $4.56From: 2010-04-01Exp: 2010-04-01→ Common Stock (2,621 underlying) - Exercise/Conversion
Common Stock
2010-04-01$4.56/sh+2,621$11,941→ 41,419 total - Award
ESPP (right to buy)
2010-04-01+2,228→ 2,228 totalExercise: $5.33From: 2010-10-01Exp: 2010-10-01→ Common Stock (2,228 underlying)
Footnotes (5)
- [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
- [F2]Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan.
- [F3]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
- [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date.
- [F5]The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001327433
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:32 PM ET
- Size
- 12.1 KB